Largest health care pharmaceutical companies by revenue

Everything the company sold in its latest fiscal year, before any cost is taken off.

Johnson & Johnson leads the 52 health care pharmaceutical companies ranked by revenue, at NZ$171.3B, ahead of Eli Lilly (NZ$118.5B) and Merck & Co (NZ$118.2B). Figures as of 20 Nov 2026, 15:29 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
52
First
Johnson & JohnsonNZ$171.3B
Median
NZ$5.8B
Combined market value
NZ$9.12T
Countries
10
Not ranked
9no revenue on file

Market values as of .

All countries
Health Care
Pharmaceuticals
NZD
Clear filters
Largest health care pharmaceutical companies by revenue
#CompanyRevenue ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Johnson & JohnsonJNJ · Health CareNZ$171.3BNZ$1.19TNZ$493.61 1.62% up 31% up United States
2Eli LillyLLY · Health CareNZ$118.5BNZ$2.21TNZ$2,476.85 0.82% up 28% up United States
3Merck & CoMRK · Health CareNZ$118.2BNZ$611BNZ$247.85 2.64% up 36% up United States
4PfizerPFE · Health CareNZ$113.8BNZ$289.4BNZ$50.78 1.40% up 10% up United States
5AbbVieABBV · Health CareNZ$111.2BNZ$927.4BNZ$524.69 1.77% up 20% up United States
6AstraZenecaAZN · Health CareNZ$106.8BNZ$497.4BNZ$320.71 0.55% up 4% down United Kingdom
7NovartisNVS · Health CareNZ$99.2BNZ$521.6BNZ$276.19 0.45% up 19% up Switzerland
8SanofiSNY · Health CareNZ$88BNZ$203.7BNZ$84.81 1.27% up 7% down France
9Bristol-Myers SquibbBMY · Health CareNZ$87.6BNZ$220.8BNZ$108.03 1.83% up 26% up United States
10Novo NordiskNVO · Health CareNZ$83.4BNZ$312BNZ$70.79 0.15% up 18% down Denmark
11Abbott LaboratoriesABT · Health CareNZ$80.6BNZ$330.6BNZ$190.89 1.07% up 19% down United States
12GSKGSK · Health CareNZ$78.8BNZ$176.9BNZ$88.24 1.48% up 1% up United Kingdom
13Takeda PharmaceuticalTAK · Health CareNZ$51.3BNZ$127.7BNZ$39.96 2.64% up 50% up Japan
14Teva Pharmaceutical IndustriesTEVA · Health CareNZ$31.4BNZ$83.3BNZ$71.37 1.84% up 59% up Israel
15Regeneron PharmaceuticalsREGN · Health CareNZ$26.1BNZ$175.3BNZ$1,694.25 1.02% up 22% up United States
16ViatrisVTRS · Health CareNZ$26BNZ$41.3BNZ$36.04 0.30% down 90% up United States
17Vertex PharmaceuticalsVRTX · Health CareNZ$21.8BNZ$242.4BNZ$956.10 0.99% up 22% up United States
18ZoetisZTS · Health CareNZ$17.2BNZ$60.3BNZ$148.37 1.00% up 34% down United States
19GrifolsGRFS · Health CareNZ$15.2BNZ$10.1BNZ$14.80 0.73% down 2% down Spain
20BeOne MedicinesONC · Health CareNZ$9.7BNZ$82.1BNZ$718.40 1.15% down 15% up Switzerland
21Elanco Animal HealthELAN · Health CareNZ$8.6BNZ$23.8BNZ$47.53 0.57% down 18% up United States
22Jazz PharmaceuticalsJAZZ · Health CareNZ$7.8BNZ$27BNZ$421.27 2.02% down 34% up Ireland
23GenmabGMAB · Health CareNZ$6.8BNZ$57.2BNZ$92.82 0.58% down 69% up Denmark
24Alnylam PharmaceuticalsALNY · Health CareNZ$6.8BNZ$36.7BNZ$273.67 1.82% up 66% down United States
25Dr. Reddy's LaboratoriesRDY · Health CareNZ$6.5BNZ$22.7BNZ$27.24 1.01% up 7% up India
26BioMarin PharmaceuticalBMRN · Health CareNZ$5.9BNZ$21.6BNZ$111.39 0.26% down 12% up United States
27United TherapeuticsUTHR · Health CareNZ$5.8BNZ$43.1BNZ$1,011.25 0.53% down 18% up United States
28Amneal PharmaceuticalsAMRX · Health CareNZ$5.5BNZ$13.5BNZ$38.61 0.72% down 79% up United States
29Royalty PharmaRPRX · Health CareNZ$4.3BNZ$71.4BNZ$124.11 0.79% up 74% up United States
30PTC TherapeuticsPTCT · Health CareNZ$3.1BNZ$8.8BNZ$105.12 0.88% down 26% down United States
31AlkermesALKS · Health CareNZ$2.7BNZ$14.2BNZ$84.44 0.56% up 61% up Ireland
32Legend BiotechLEGN · Health CareNZ$1.9BNZ$5.6BNZ$28.79 1.65% down 43% down United States
33Madrigal PharmaceuticalsMDGL · Health CareNZ$1.7BNZ$16.6BNZ$712.76 1.20% down 28% down United States
34Ionis PharmaceuticalsIONS · Health CareNZ$1.7BNZ$8.3BNZ$49.99 0.99% up 64% down United States
35Arrowhead PharmaceuticalsARWR · Health CareNZ$1.5BNZ$11.1BNZ$78.40 1.23% down 8% up United States
36Ascendis PharmaASND · Health CareNZ$1.5BNZ$30.2BNZ$460.28 1.10% down 22% up Denmark
37Corcept TherapeuticsCORT · Health CareNZ$1.4BNZ$12.8BNZ$116.90 1.06% down 16% down United States
38Kiniksa Pharmaceuticals InternationalKNSA · Health CareNZ$1.2BNZ$13.4BNZ$170.59 0.30% up 125% up United Kingdom
39Axsome TherapeuticsAXSM · Health CareNZ$1.2BNZ$12.6BNZ$240.20 2.64% down 9% down United States
40TG TherapeuticsTGTX · Health CareNZ$1.1BNZ$17.8BNZ$117.59 0.32% down 103% up United States
41InsmedINSM · Health CareNZ$1.1BNZ$58.1BNZ$264.64 0.75% up 27% down United States
42Mirum PharmaceuticalsMIRM · Health CareNZ$947.9MNZ$11.5BNZ$176.45 1.60% up 35% up United States
43BridgeBio PharmaBBIO · Health CareNZ$912.9MNZ$27.4BNZ$140.66 1.05% down 15% up United States
44Travere TherapeuticsTVTX · Health CareNZ$892.3MNZ$8.5BNZ$88.26 0.50% up 39% up United States
45Ligand PharmaceuticalsLGND · Health CareNZ$487.5MNZ$10.5BNZ$524.73 0.57% up 44% up United States
46Rhythm PharmaceuticalsRYTM · Health CareNZ$345MNZ$14.4BNZ$207.73 2.19% down 15% up United States
47CytokineticsCYTK · Health CareNZ$160.1MNZ$13.4BNZ$96.46 3.09% up 21% down United States
48Protagonist TherapeuticsPTGX · Health CareNZ$83.7MNZ$14.4BNZ$221.00 2.00% down 45% up United States
49Roivant SciencesROIV · Health CareNZ$15MNZ$51.3BNZ$70.80 0.05% down 93% up United Kingdom
50Dianthus TherapeuticsDNTH · Health CareNZ$3.7MNZ$8.6BNZ$152.26 1.28% down 105% up United States
51Spyre TherapeuticsSYRE · Health CareNZ$0NZ$16.6BNZ$175.03 1.40% down 302% up United States
52Praxis Precision MedicinesPRAX · Health CareNZ$0NZ$15.7BNZ$560.36 0.87% down 83% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.8183 NZD). 9 companies have no revenue on file and are not ranked here.

Questions and answers

Which health care pharmaceutical companies rank first by revenue?

Johnson & Johnson (NZ$171.3B), Eli Lilly (NZ$118.5B) and Merck & Co (NZ$118.2B) are the top three of the 52 health care pharmaceutical companies ranked by revenue as of 20 Nov 2026, 15:29 UTC.

How many health care pharmaceutical companies are in this ranking?

52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.

What are these health care pharmaceutical companies worth together?

The 52 health care pharmaceutical companies ranked by revenue have a combined market value of NZ$9.12T as of 20 Nov 2026, 15:29 UTC.

What does ranking by revenue measure?

Everything the company sold in its latest fiscal year, before any cost is taken off.

Cite this page

Funkfolio, “Largest health care pharmaceutical companies by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=revenue

Underlying data: Yahoo Finance; SEC EDGAR.